A

Apellis Pharmaceuticals
D

APLS

33.220
USD
0.00
(0.00%)
Market Open
Volume
14,589
EPS
-2
Div Yield
-
P/E
-16
Market Cap
4,132,336,025
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.02500
    (0.78%)
    3.22500 USD
    AMGN
    AMGN
    -1.93
    (-0.73%)
    261.73 USD
    A
    ANAB
    -0.210
    (-1.44%)
    14.360 USD
    A
    ARWR
    0.060
    (0.31%)
    19.510 USD
    A
    ATNX
    -0.34000
    (-19.65%)
    1.43000 USD
    BGNE
    BGNE
    0.670
    (0.38%)
    177.120 USD
    BIIB
    BIIB
    0.650
    (0.44%)
    147.240 USD
    BMY
    BMY
    -0.230
    (-0.40%)
    57.050 USD
    C
    CRBP
    -0.070
    (-0.54%)
    12.890 USD
    E
    EXEL
    0.040
    (0.12%)
    33.320 USD
    GE
    GE
    -0.450
    (-0.27%)
    168.260 USD
    GSK
    GSK
    0.175
    (0.52%)
    33.770 USD
    I
    INCY
    0.130
    (0.19%)
    69.040 USD
    More
News

Title: Apellis Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.